Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones

Journal of Virological Methods
Weijia WangHua Zhu

Abstract

Human cytomegalovirus (HCMV) genome manipulation has always been difficult. Recently, the introduction of full-length HCMV DNA into Escherichia coli as an artificial bacterial chromosome (BAC) clone has allowed reliable targeted mutagenesis. Here, we show the next generation of improvement in designing recombinant HCMV, which will also be applicable to other viral BAC clones. An inducible origin of replication linked with an antibiotic resistance marker was used as a cassette for targeted replacement of sequences within a HCMV BAC clone, TowneBAC. The origin of replication allowed for the induction of increased amounts BAC DNA that improved recovery, ease of use and transfections for mutant viruses. By specific deletion of UL147 and the recombinant GFP gene, we have shown that targeted deletion of a gene and selection for a recombinant genome are coupled with the ability to amplify the BAC clone DNA. These HCMV BAC clones were amplified approximately 10-fold. In the case of the removal of GFP from the clone TowneBAC shown in this study, the resulting BAC DNA preparation following amplification was used for successful primary cell transfection. Both parental and deletion BAC clone transfections gave similar levels of recombinant...Continue Reading

References

Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·M MesserleU H Koszinowski
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·D YuD L Court
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Jan 3, 2001·Genesis : the Journal of Genetics and Development·S SwaminathanS K Sharan
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Dong YuThomas Shenk
Nov 1, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eain MurphyThomas E Shenk
Nov 18, 2003·Annual Review of Genetics·Finbarr Hayes
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Walter DunnFenyong Liu
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eain MurphyThomas E Shenk
Dec 16, 2003·BMC Molecular Biology·Kenan C Murphy, Kenneth G Campellone
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zsuzsanna Izsvák, Zoltán Ivics

❮ Previous
Next ❯

Citations

Jan 16, 2010·The Journal of Molecular Diagnostics : JMD·Roberta M MadejGeorge J Schneider
Jan 24, 2009·Journal of Virological Methods·Kalpana DulalHua Zhu
Nov 9, 2007·Plasmid·Yaw-Shin OoiKumaran Narayanan
Jan 17, 2013·The Journal of Molecular Diagnostics : JMD·Ross J HaynesMarcia J Holden
Sep 10, 2011·Expert Review of Molecular Diagnostics·Marcia J HoldenLisa V Kalman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.